Vertex Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Vertex Pharmaceuticals exhibits at Booth 1639 at ASH 2026 in New Orleans, and takes part in 2 sessions. Vertex Pharmaceuticals brings approved treatments for sickle cell disease and beta thalassemia, alongside medicines for cystic fibrosis and acute pain.
| Organization | ASH 2026 Attendance |
|---|---|
Vertex Pharmaceuticals Boston, MA | |
Biotechnology company whose approved medicines treat sickle cell disease, beta thalassemia, cystic fibrosis and acute pain, with a broad clinical pipeline. | Booth Exhibiting at Booth 1639 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Session Fri Dec 11 1:35pm–3:55pm Session Fri Dec 11 2:45pm–3:15pm |
Find decision makers at Vertex Pharmaceuticals
Tell us what you sell and we’ll find the people at Vertex Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction